CYB5R3
CYB5R3 (cytochrome b5 reductase 3, also known as B5R and DIA1) is a flavoprotein that catalyses the reduction of cytochrome b5 using NADH as the electron donor. It exists as a membrane-bound form in somatic cells and a soluble form in erythrocytes. Browse Assay Genie's current range of CYB5R3 research reagents below, or read on for the biology behind the target.
CYB5R3 catalyses the reduction of two molecules of cytochrome b5 using NADH as the electron donor. It belongs to the flavoprotein pyridine nucleotide cytochrome reductase family, and HGNC places it in the cytochrome b5 reductases and flavoproteins gene groups. In UniProt, the enzyme is annotated in the endoplasmic reticulum membrane, the mitochondrion outer membrane and the cytoplasm.
The CYB5R3 gene encodes two forms of the enzyme. The membrane-bound form is found in somatic cells, anchored in the endoplasmic reticulum, mitochondrial and other membranes. It sits mainly on the cytoplasmic side of the endoplasmic reticulum and functions in the desaturation and elongation of fatty acids, in cholesterol biosynthesis and in drug metabolism. The membrane-bound form has both a membrane-binding domain and a catalytic domain. The soluble form is located in the soluble fraction of circulating erythrocytes, where it is involved in methemoglobin reduction, and it has only the catalytic domain. Alternate splicing results in multiple transcript variants, so researchers working with the CYB5R3 protein should consider which form they are studying.
Mutations in the CYB5R3 gene cause methemoglobinemias, which links the enzyme to erythrocyte redox biology. The gene was previously named diaphorase (NADH) (cytochrome b-5 reductase), which explains the alias DIA1; B5R is another alias. Mouse and rat both have a Cyb5r3 ortholog, which allows the enzyme to be studied in rodent models.
The soluble erythrocyte form is involved in methemoglobin reduction, and mutations in the gene cause methemoglobinemias.
The membrane-bound form functions in the desaturation and elongation of fatty acids at the cytoplasmic face of the endoplasmic reticulum.
The membrane-bound enzyme contributes to cholesterol biosynthesis, making it relevant to studies of endoplasmic reticulum lipid metabolism.
CYB5R3 functions in drug metabolism through electron transfer to cytochrome b5, a role studied in membrane-bound redox systems.
CYB5R3 catalyses the reduction of two molecules of cytochrome b5 using NADH as the electron donor. The membrane-bound form functions in fatty acid desaturation and elongation, cholesterol biosynthesis and drug metabolism, while the soluble erythrocyte form is involved in methemoglobin reduction.
B5R and DIA1 are aliases for the gene. DIA1 reflects its previous HGNC name, diaphorase (NADH) (cytochrome b-5 reductase). The current name, cytochrome b5 reductase 3, and the UniProt name, NADH-cytochrome b5 reductase 3, describe the same enzyme.
Mutations in the CYB5R3 gene cause methemoglobinemias. Orthologs named Cyb5r3 are present in both mouse and rat, so the enzyme can be studied in rodent systems; check the datasheet of any product for its validated reactivity.
Other cytochrome b5 reductases, cytochrome b5 and cytochrome b family members involved in electron transfer and redox biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P00387; product specifications from Assay Genie datasheets.